Subscribe to Technical Bulletin
Tips
The remarkable process by which a single totipotent zygote develops into the approximately 37 trillion c
1
The remarkable process by which a single totipotent zygote develops into the approximately 37 trillion c
2

Protocal

  • New Insights into Type III CRISPR System: Cryo-EM Reveals Selective Synthesis of Cyclic Oligoadenylates (cOA) as a Second Messenger in the System

    LATEST DISCOVERY

    New Insights into Type III CRISPR System: Cryo-EM Reveals Selective Synthesis of Cyclic Oligoadenylates (cOA) as a Second Messenger in the System

  • [Literature Review] CRISPR Knockout Library Screening Identifies TMEFF1 as a Neuron-Specific Restriction Factor for HSV-1

    LATEST DISCOVERY

    [Literature Review] CRISPR Knockout Library Screening Identifies TMEFF1 as a Neuron-Specific Restriction Factor for HSV-1

  • [Weekly News] Breakthrough in Gene Editing: Overcoming Immunogenicity with Cas Enzyme Mutants

    LATEST DISCOVERY

    [Weekly News] Breakthrough in Gene Editing: Overcoming Immunogenicity with Cas Enzyme Mutants

  • [Weekly News] CRISPR Library Screening Uncovers ALCAM as a Novel Molecular Target for Human Adenovirus B

    LATEST DISCOVERY

    [Weekly News] CRISPR Library Screening Uncovers ALCAM as a Novel Molecular Target for Human Adenovirus B

  • [Weekly News] CRISPR-StAR: High-Resolution Genetic Screening Innovation

    LATEST DISCOVERY

    [Weekly News] CRISPR-StAR: High-Resolution Genetic Screening Innovation

  • [Weekly News]CRISPR screening reveals synthetic lethal interactions in cancer, providing new targets for therapy

    LATEST DISCOVERY

    [Weekly News]CRISPR screening reveals synthetic lethal interactions in cancer, providing new targets for therapy

  •  [Literature Review] CRISPR gene editing combined with magnetocaloric activation: A new strategy to assist precision medicine in cancer

    LATEST DISCOVERY

    [Literature Review] CRISPR gene editing combined with magnetocaloric activation: A new strategy to assist precision medicine in cancer

  • [Weekly News] Multiplexed CRISPR Arrayed Libraries: Advancing Whole-Genome Targeting for Knockout, Activation, and Silencing Research

    LATEST DISCOVERY

    [Weekly News] Multiplexed CRISPR Arrayed Libraries: Advancing Whole-Genome Targeting for Knockout, Activation, and Silencing Research

  • [Weekly News] CRISPR Library Screening: The Key Role of EV-DNA Structure in Kupffer Cell Mediated Antitumor Immunity

    LATEST DISCOVERY

    [Weekly News] CRISPR Library Screening: The Key Role of EV-DNA Structure in Kupffer Cell Mediated Antitumor Immunity

  • [Star of the Month] Human Whole Genome CRISPR/Cas9 Knockout Library and Human RNA Binding Protein Library

    LATEST DISCOVERY

    [Star of the Month] Human Whole Genome CRISPR/Cas9 Knockout Library and Human RNA Binding Protein Library

  •  [Weekly News] Genome-Wide CRISPR Screening: Uncovering New Host Factors to Optimize Rotavirus Vaccine Production

    LATEST DISCOVERY

    [Weekly News] Genome-Wide CRISPR Screening: Uncovering New Host Factors to Optimize Rotavirus Vaccine Production

  • [Literature Review] Unlocking CRISPR-Cas12a's Full Potential: Enhancing Trans-Cleavage with Variants

    LATEST DISCOVERY

    [Literature Review] Unlocking CRISPR-Cas12a's Full Potential: Enhancing Trans-Cleavage with Variants

  • [Literature Review] Gene Knockout of ERAP1 Provides New Insights for Optimizing Tumor Immunotherapy

    LATEST DISCOVERY

    [Literature Review] Gene Knockout of ERAP1 Provides New Insights for Optimizing Tumor Immunotherapy

  • [Weekly News] CRISPR Screening Revealing TMEM106B as a Mediator of an ACE2-Independent Infection Pathway for SARS-CoV-2

    LATEST DISCOVERY

    [Weekly News] CRISPR Screening Revealing TMEM106B as a Mediator of an ACE2-Independent Infection Pathway for SARS-CoV-2

  • [Weekly News] CRISPR/Cas9 Screening Unlocks Secrets of Stem Cell Power

    LATEST DISCOVERY

    [Weekly News] CRISPR/Cas9 Screening Unlocks Secrets of Stem Cell Power

Contact US
*
*
*
*
web logo
Kathy
Email: info@editxor.com
Tel: +1 224345 1927 (USA)
Tel: 833 2263234(USA ToIl-free)
Tel: +86 19120102676 (Intl)